- ►pharmyaring.com [PDF] SE Inzucchi - Jama, 2002 - Am Med Assoc Context Care of patients with type 2 diabetes has been revolutionized throughout
the past several years—first, by the realization of the importance of tight
glycemic control in forestalling complications, and second, by the ... Cited by 608 - Related articles - BL Direct - All 18 versions
- ►karolinskauniversitetssjukhuset.se [PDF] SR Salpeter, E Greyber, GA Pasternak, EE … - Archives of Internal Medicine, 2003 - archinte.highwire.org Methods A comprehensive search was performed to identify all comparative trials
or observational cohort studies published between January 1, 1959, and March 31,
2002, that evaluated metformin therapy, alone or in combination with other ... Cited by 322 - Related articles - BL Direct - All 16 versions
J Rosenstock, D Sugimoto, P Strange, JA … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—A1C improvements from baseline were similar in both groups (−1.7 vs.
−1.5% for insulin glargine vs. rosiglitazone, respectively); however, when
baseline A1C was >9.5%, the reduction of A1C with insulin glargine was ... Cited by 100 - Related articles - BL Direct - All 8 versions
- ►adisonline.com [PDF] M Rendell - Drugs, 2004 - ingentaconnect.com The sulphonylureas act by triggering insulin release from the pancreatic β
cell. Abstract A specific site on the adenosine triphosphate (ATP)-sensitive
potassium channels is occupied by sulphonylureas leading to closure of the ... Cited by 87 - Related articles - BL Direct - All 7 versions
JL Chan, MJ Abrahamson - Mayo Clinic Proceedings, 2003 - mayoclinicproceedings.com Type 2 diabetes mellitus is a chronic metabolic disorder associated with high
morbidity and mortality from long- term microvascular and macrovascular
complications. Evidence from randomized controlled trials indicates that ... Cited by 76 - Related articles - View as HTML - BL Direct - All 12 versions
AF Ayyobi, JD Brunzell - The American journal of cardiology, 2003 - Elsevier Metabolic abnormalities associated with the metabolic syndrome are also present
in patients with type 2 diabetes mellitus and in those with familial combined
hyperlipidemia (FCHL). These abnormalities include central obesity, insulin ... Cited by 78 - Related articles - All 10 versions
GE Dailey, MA Noor, JS Park, S Bruce, FT … - The American journal of medicine, 2004 - Elsevier Following an open-label, lead-in phase to optimize the dosing of
glyburide/metformin tablets, 365 patients randomly received additive therapy
comprising rosiglitazone (4 mg once daily) or placebo for 24 weeks. Based ... Cited by 64 - Related articles - All 9 versions
H Walter, G Lubben - Drugs, 2005 - ingentaconnect.com Worsening glycaemic control in type 2 diabetes mellitus relates to a decline in
Abstract β-cell function, associated with impaired negative feedback regulation
of insulin release. Insulin resistance, the 'traditional' cornerstone ... Cited by 59 - Related articles - All 5 versions
- ►diabetesjournals.org SE Inzucchi, FA Masoudi, Y Wang, M … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We conducted a retrospective cohort study of
24,953 Medicare beneficiaries with diabetes discharged after hospitalization
with AMI between April 1998 and March 1999 or July 2000 and June 2001. The ... Cited by 55 - Related articles - BL Direct - All 5 versions
